BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 9973592)

  • 1. Hepatitis C in state correctional facilities.
    Spaulding A; Greene C; Davidson K; Schneidermann M; Rich J
    Prev Med; 1999 Jan; 28(1):92-100. PubMed ID: 9973592
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Opportunities to address the hepatitis C epidemic in the correctional setting.
    Boutwell AE; Allen SA; Rich JD
    Clin Infect Dis; 2005 Apr; 40 Suppl 5():S367-72. PubMed ID: 15768350
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The spectrum of chronic hepatitis C virus infection in the Virginia Correctional System: development of a strategy for the evaluation and treatment of inmates with HCV.
    Sterling RK; Brown RS; Hofmann CM; Luketic VA; Stravitz RT; Sanyal AJ; Contos MJ; Mills AS; Smith V; Shiffman ML
    Am J Gastroenterol; 2005 Feb; 100(2):313-21. PubMed ID: 15667488
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HIV rate in CA prisons higher than in community.
    AIDS Alert; 1996 Feb; 11(2):23. PubMed ID: 11363237
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Using a surveillance system to identify and treat newly acquired hepatitis C infection.
    Walsh N; Lim M; Hellard M
    J Gastroenterol Hepatol; 2008 Dec; 23(12):1891-4. PubMed ID: 19120877
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcome of screening for hepatitis C virus infection based on risk factors.
    Mallette C; Flynn MA; Promrat K
    Am J Gastroenterol; 2008 Jan; 103(1):131-7. PubMed ID: 17894850
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence and correlates of hepatitis C virus infection among inmates entering the California correctional system.
    Ruiz JD; Molitor F; Sun RK; Mikanda J; Facer M; Colford JM; Rutherford GW; Ascher MS
    West J Med; 1999 Mar; 170(3):156-60. PubMed ID: 10214102
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of risk-based hepatitis C screening and the true seroprevalence in an urban prison system.
    Kuncio DE; Newbern EC; Fernandez-ViƱa MH; Herdman B; Johnson CC; Viner KM
    J Urban Health; 2015 Apr; 92(2):379-86. PubMed ID: 25795212
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transmission of hepatitis B virus in correctional facilities--Georgia, January 1999-June 2002.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2004 Aug; 53(30):678-81. PubMed ID: 15295311
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment and proposal of a new combination of screening criteria for hepatitis C in France.
    King LA; Le Strat Y; Meffre C; Delarocque-Astagneau E; Desenclos JC
    Eur J Public Health; 2009 Oct; 19(5):527-33. PubMed ID: 19667051
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Hepatitis C virus screening in drug users in an addiction out-patient unit].
    Grando-Lemaire V; Goisset P; Sorge F; Trinchet JC; Castera L; Roulot D; Sitruk V; Beaugrand M
    Gastroenterol Clin Biol; 2002 Dec; 26(12):1091-6. PubMed ID: 12520196
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatitis C virus infection in South Australian prisoners: seroprevalence, seroconversion, and risk factors.
    Miller ER; Bi P; Ryan P
    Int J Infect Dis; 2009 Mar; 13(2):201-8. PubMed ID: 18790659
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Budget Impact Analysis of Newly Available Hepatitis C Therapeutics and the Financial Burden on a State Correctional System.
    Nguyen JT; Rich JD; Brockmann BW; Vohr F; Spaulding A; Montague BT
    J Urban Health; 2015 Aug; 92(4):635-49. PubMed ID: 25828149
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatitis B and C in the context of HIV disease: implications for incarcerated populations.
    Spaulding AC; Lally M; Rich JD; Dieterich DT
    AIDS Read; 1999 Oct; 9(7):481-91. PubMed ID: 12737140
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Addressing tri-morbidity (hepatitis C, psychiatric disorders, and substance use): the importance of routine mental health screening as a component of a comanagement model of care.
    Fireman M; Indest DW; Blackwell A; Whitehead AJ; Hauser P
    Clin Infect Dis; 2005 Apr; 40 Suppl 5():S286-91. PubMed ID: 15768336
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Routine hepatitis C virus screening in pregnancy: a cost-effectiveness analysis.
    Plunkett BA; Grobman WA
    Am J Obstet Gynecol; 2005 Apr; 192(4):1153-61. PubMed ID: 15846195
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatitis C in schizophrenia: screening experience in a community-dwelling clozapine cohort.
    Freudenreich O; Gandhi RT; Walsh JP; Henderson DC; Goff DC
    Psychosomatics; 2007; 48(5):405-11. PubMed ID: 17878499
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correctional treatment for co-occurring disorders: results of a national survey.
    Peters RH; LeVasseur ME; Chandler RK
    Behav Sci Law; 2004; 22(4):563-84. PubMed ID: 15282840
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prisoners' attitudes toward Hepatitis B vaccination.
    Vallabhaneni S; Macalino GE; Reinert SE; Schwartzapfel B; Wolf FA; Rich JD
    Prev Med; 2004 Jun; 38(6):828-33. PubMed ID: 15193905
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tattooing in prisons--not such a pretty picture.
    Hellard ME; Aitken CK; Hocking JS
    Am J Infect Control; 2007 Sep; 35(7):477-80. PubMed ID: 17765561
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.